Close

Exploring The Patient’s Journey: A Look At The Onboarding Process

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Managing Quality and Regulatory Risks in Pharmaceutical Technology Transfer

Technology transfer moves more than manufacturing instructions. It moves process knowledge, supplier dependencies, labeling requirements, packaging specifications, and the evidence needed to demonstrate control. For medical device manufacturers, including those supporting drug-device combination products, these interfaces can become recurring sources of compliance gaps during site transitions, acquisitions, and remediation. The central problem is often not a missing procedure. It is a quality system that allows connected activities to change independently. A label revision may be approved while packaging artwork, supplier instructions, or production-system data still reflect an obsolete version. Staying inspection-ready requires manufacturers to manage these dependencies as one controlled system. Why Compliance Gaps Keep Recurring Findings are treated as documentation defects Revising a procedure can resolve an immediate discrepancy without changing the behavior that caused it. If unclear decision rights, weak escalation, or ineffective training remain, the same failure may surface elsewhere. Corrective and preventive action should distinguish the observed finding from its underlying cause and establish how effectiveness will be demonstrated. Ownership is divided across connected functions Quality, Regulatory Affairs, labeling, packaging engineering, operations, suppliers, and digital-system owners often maintain separate workflows. Each team may complete its assigned task while an interface remains uncontrolled. For example, changing an instruction for use can affect packaging configuration, translations, technical documentation, inventory disposition, and release controls. Transitions expose unresolved weaknesses Acquisitions and site transfers can introduce conflicting procedures, incomplete knowledge transfer, or different assumptions about validated processes. Regulatory changes add further demands. When these events coincide with CAPA or change-control backlogs, teams may prioritize administrative closure over risk reduction. Without a coordinated impact assessment, local fixes can create new gaps downstream. Establish the Regulatory Baseline Inspection readiness starts with knowing which requirements apply to the product, activity, and market. Pharmaceutical, device, and combination-product obligations are not interchangeable; transfer planning should identify the applicable requirements rather than assume one quality framework covers every operation. According to FDA’s Quality Management System Regulation overview and FAQs, the QMSR became effective on February 2, 2026, incorporates ISO 13485:2016 by reference, and introduced the updated device inspection process under Compliance Program 7382.850. ISO 13485 certification does not exempt a manufacturer from FDA inspection or guarantee compliance with FDA requirements. For devices marketed in the European Union, Regulation (EU) 2017/745, Annex I, Section 23, provides the primary requirements for information supplied with devices, including labels and instructions for use. Teams should assess the applicable provisions alongside relevant language, product-specific, and market requirements. A labeling review should therefore evaluate required content and consistency with the device’s intended purpose and supporting documentation—not merely artwork accuracy. How to Identify the Real Gaps Begin with a cross-functional assessment that follows actual product and information flows. Select representative transfers, label changes, supplier changes, and CAPAs, then trace each from initiation through implementation and effectiveness review. Map dependencies: Identify affected specifications, suppliers, packaging components, systems, validation activities, and training. Compare records with practice: Check whether approved procedures match what operators and reviewers actually do. Test traceability: Follow a requirement through technical documentation, labeling, production instructions, and release evidence. Examine recurrence: Look for repeated deviations, reopened actions, overdue changes, and findings shared across sites. Assess capacity: Determine whether qualified owners have enough time and authority to complete corrective work. Prioritize gaps by potential patient or user harm, regulatory impact, likelihood of recurrence, and detectability. Document the rationale; an old overdue item is not automatically more important than a newly identified high-risk weakness. Align Quality, Labeling, Packaging, and Change Control Create a coordinated remediation plan with one accountable owner for each action, named contributors, acceptance criteria, and required evidence. Separate immediate containment from systemic correction. Containment might prevent obsolete labels from being issued; correction might redesign approval and implementation controls so obsolete versions cannot return. Use change control as the integration point. Before approval, evaluate effects on regulatory submissions or notifications, technical documentation, supplier controls, packaging performance, validation, electronic master data, inventory, and training. Record both identified impacts and justified decisions that particular activities are unaffected. During technology transfer, define readiness gates before production or release responsibilities move. These should address the transfer of process knowledge, acceptance criteria, receiving-site capability, required qualification or validation, approved documents, and personnel competence. The appropriate evidence depends on the product and process; a generic checklist cannot replace a documented assessment. Finally, verify implementation where the work happens. Confirm that current instructions are available, suppliers received approved requirements, systems contain correct versions, and affected personnel can perform their tasks. A signed approval is not evidence that every downstream change took effect. Mistakes That Undermine Inspection Readiness Closing CAPAs on task completion alone: Effectiveness checks should test whether the underlying failure has been controlled. Updating labels in isolation: Assess packaging, supplier, system, documentation, and inventory consequences. Counting closures instead of evidence: Dashboards need defensible records behind their status indicators. ...

State of API & Peptide CDMO Capacity

Pharmaceutical companies planning peptide or complex small-molecule launches are...

What Goes Into Synthetic Urine? The Chemistry Behind Replicating a Biological Fluid

Synthetic urine sounds simple until you look closely at...
- Advertisement -

As a healthcare provider, you know how important it is to create a positive experience for your patients from the moment they walk through your doors. One crucial aspect of this experience is the onboarding process.  

This is where patients register for their appointment, provide their medical history, and sign consent forms. It’s a critical step in the patient’s journey and sets the tone for the rest of their visit. 

That’s why it’s essential to have a streamlined, efficient process in place. It’s also where patient registration software comes in. 

What Makes Patient Onboarding Crucial?

Efficient patient onboarding matters for several reasons. 

Firstly, it establishes a patient’s first impression of a healthcare provider, setting the tone for the entire patient-practitioner relationship. A smooth, organized, quick onboarding process can instil trust and confidence in the healthcare provider’s competence.

Secondly, it helps reduce patient anxiety and confusion. When they clearly understand the process, their responsibilities, and what they can expect from the care provider, they are more likely to engage fully in their healthcare journey.  

Thirdly, it significantly improves patient flow within a healthcare facility.

Lastly, streamlined patient onboarding can free up valuable staff time and resources. That enables healthcare providers to focus better on patient care rather than administrative tasks.

Therefore, efficient patient onboarding is beneficial not just for patients but also for healthcare providers and staff. 

What Is Patient Registration Software? 

Patient registration software is a tool that automates registering patients for appointments. It allows patients to complete their registration forms online before their appointment, saving them time and hassle.  

The software can also integrate with electronic health record (EHR) systems, ensuring that patient information is accurate and up to date—and does not have to be filled out again come appointment time. Doing so reduces patient waiting time, a huge factor correlating to overall satisfaction with the services offered by the clinic or hospital.  

The Benefits Of Patient Registration Software 

Implementing patient registration software can benefit both patients and healthcare providers. Here are just a few of the perks it offers: 

  • Improved patient convenience: Patients appreciate the convenience of completing their registration forms online before their appointment. It saves them time and reduces stress, making for a more positive experience overall—and more positive reviews.  
  • Increased efficiency: By automating the registration process, healthcare providers and their staff can save time and reduce errors. They spend less time on paperwork and more on patient care. 
  • Better data accuracy: Patient registration software can integrate with EHR systems, ensuring that patient information is accurate and current. That reduces the risk of errors and ensures the continuity of care plans.  
  • Streamlined workflow: Patient registration software can help healthcare providers streamline workflow and reduce bottlenecks. By automating the registration process, staff can focus on other tasks, improving overall efficiency and elevating the quality of care they provide.

One can see from this list how much patient registration software meets and raises care standards. Consider investing in the ideal one for your facility.

How Patient Registration Software Works

The typical onboarding process goes like this: 

  1. Before sending any forms, ensure you have the patient’s consent to email them. It would help if you informed them about the privacy and security implications of sending sensitive health information over email. Depending on their preferences, patients receive an email, text message, or both with a link to their registration forms.  
  2. Patients complete their registration forms online, including their medical history and insurance information. Sending the form ahead of time allows patients to fill it out at their convenience, helping to speed up the registration process and reducing waiting times when they arrive for their appointment.

Email the form to the patient with clear instructions on how to fill it out and return it. Some patients can fill it out digitally and email it back, while others prefer to print it out, fill it out by hand, and bring it to their appointment.   

  1. Protecting patient information is important. Use a secure email system that complies with the relevant legislation, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States.  
  2. The software automatically verifies insurance eligibility and checks for any missing information.    
  3. The patient’s information is securely transmitted to the healthcare provider’s EHR system. Sometimes, it needs to be corrected (e.g., birthdate is the current year) or completed, such as medication details, past diseases, allergies, vaccination, and other relevant data. Such information can be updated during the appointment. 

If you don’t receive the completed form within a certain period, follow up with the patient to remind them to complete it. Additionally, it’s crucial to ensure that any called-in questions about the email are properly secured. Even spouses, children, partners, or next-of-kin should not be privy to personal health information without explicit consent.

Tips For Implementing Patient Registration Software 

Implementing patient registration software can be a significant change for healthcare providers. Here are some tips to make the transition smoother: 

  • Communicate with patients: Let patients know about the new registration process and how it works. Provide clear instructions and answer any questions they may have.  
  • Train staff: Ensure staff members are trained to use the software and understand the new workflow.  
  • Test the software: Before implementing the software, thoroughly ensure it integrates with your EHR system and works as expected.  
  • Monitor performance: Once the software is in place, monitor its performance and gather feedback from staff and patients. Use that to make improvements and refine the process. 

Takeaways

The onboarding process is a critical step in the patient’s journey, and patient registration software can help healthcare providers create a more positive experience for their patients.

If you’re considering implementing patient registration software, communicate with your patients, train your staff, test the software thoroughly, and monitor its performance. With the right tools and processes, you can create a more efficient, streamlined, and patient-focused onboarding experience.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Latest stories

Related stories

Managing Quality and Regulatory Risks in Pharmaceutical Technology Transfer

Technology transfer moves more than manufacturing instructions. It moves process knowledge, supplier dependencies, labeling requirements, packaging specifications, and the evidence needed to demonstrate control. For medical device manufacturers, including those supporting drug-device combination products, these interfaces can become recurring sources of compliance gaps during site transitions, acquisitions, and remediation. The central problem is often not a missing procedure. It is a quality system that allows connected activities to change independently. A label revision may be approved while packaging artwork, supplier instructions, or production-system data still reflect an obsolete version. Staying inspection-ready requires manufacturers to manage these dependencies as one controlled system. Why Compliance Gaps Keep Recurring Findings are treated as documentation defects Revising a procedure can resolve an immediate discrepancy without changing the behavior that caused it. If unclear decision rights, weak escalation, or ineffective training remain, the same failure may surface elsewhere. Corrective and preventive action should distinguish the observed finding from its underlying cause and establish how effectiveness will be demonstrated. Ownership is divided across connected functions Quality, Regulatory Affairs, labeling, packaging engineering, operations, suppliers, and digital-system owners often maintain separate workflows. Each team may complete its assigned task while an interface remains uncontrolled. For example, changing an instruction for use can affect packaging configuration, translations, technical documentation, inventory disposition, and release controls. Transitions expose unresolved weaknesses Acquisitions and site transfers can introduce conflicting procedures, incomplete knowledge transfer, or different assumptions about validated processes. Regulatory changes add further demands. When these events coincide with CAPA or change-control backlogs, teams may prioritize administrative closure over risk reduction. Without a coordinated impact assessment, local fixes can create new gaps downstream. Establish the Regulatory Baseline Inspection readiness starts with knowing which requirements apply to the product, activity, and market. Pharmaceutical, device, and combination-product obligations are not interchangeable; transfer planning should identify the applicable requirements rather than assume one quality framework covers every operation. According to FDA’s Quality Management System Regulation overview and FAQs, the QMSR became effective on February 2, 2026, incorporates ISO 13485:2016 by reference, and introduced the updated device inspection process under Compliance Program 7382.850. ISO 13485 certification does not exempt a manufacturer from FDA inspection or guarantee compliance with FDA requirements. For devices marketed in the European Union, Regulation (EU) 2017/745, Annex I, Section 23, provides the primary requirements for information supplied with devices, including labels and instructions for use. Teams should assess the applicable provisions alongside relevant language, product-specific, and market requirements. A labeling review should therefore evaluate required content and consistency with the device’s intended purpose and supporting documentation—not merely artwork accuracy. How to Identify the Real Gaps Begin with a cross-functional assessment that follows actual product and information flows. Select representative transfers, label changes, supplier changes, and CAPAs, then trace each from initiation through implementation and effectiveness review. Map dependencies: Identify affected specifications, suppliers, packaging components, systems, validation activities, and training. Compare records with practice: Check whether approved procedures match what operators and reviewers actually do. Test traceability: Follow a requirement through technical documentation, labeling, production instructions, and release evidence. Examine recurrence: Look for repeated deviations, reopened actions, overdue changes, and findings shared across sites. Assess capacity: Determine whether qualified owners have enough time and authority to complete corrective work. Prioritize gaps by potential patient or user harm, regulatory impact, likelihood of recurrence, and detectability. Document the rationale; an old overdue item is not automatically more important than a newly identified high-risk weakness. Align Quality, Labeling, Packaging, and Change Control Create a coordinated remediation plan with one accountable owner for each action, named contributors, acceptance criteria, and required evidence. Separate immediate containment from systemic correction. Containment might prevent obsolete labels from being issued; correction might redesign approval and implementation controls so obsolete versions cannot return. Use change control as the integration point. Before approval, evaluate effects on regulatory submissions or notifications, technical documentation, supplier controls, packaging performance, validation, electronic master data, inventory, and training. Record both identified impacts and justified decisions that particular activities are unaffected. During technology transfer, define readiness gates before production or release responsibilities move. These should address the transfer of process knowledge, acceptance criteria, receiving-site capability, required qualification or validation, approved documents, and personnel competence. The appropriate evidence depends on the product and process; a generic checklist cannot replace a documented assessment. Finally, verify implementation where the work happens. Confirm that current instructions are available, suppliers received approved requirements, systems contain correct versions, and affected personnel can perform their tasks. A signed approval is not evidence that every downstream change took effect. Mistakes That Undermine Inspection Readiness Closing CAPAs on task completion alone: Effectiveness checks should test whether the underlying failure has been controlled. Updating labels in isolation: Assess packaging, supplier, system, documentation, and inventory consequences. Counting closures instead of evidence: Dashboards need defensible records behind their status indicators. ...

State of API & Peptide CDMO Capacity

Pharmaceutical companies planning peptide or complex small-molecule launches are...

What Goes Into Synthetic Urine? The Chemistry Behind Replicating a Biological Fluid

Synthetic urine sounds simple until you look closely at...

Danaher Prepares to Introduce Advanced AI-Powered Laboratory

In a significant step for pharmaceutical research, Danaher has...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »